Dear Dr Raine,
Would you please explain why 11 new licences for benzodiazepines were issued in the last three years, as this group of drugs has been identified as a risk in the recent Department of Health review on addiction to prescribed medicine, and the more licences that are issued, the more an upward pressure will be caused on prescribing as each Market Authorisation Holder works to increase their share of the market?
Yours sincerely,
John Perrott